Summary
The computed 12-month bankruptcy probability of LuMed is 3.4% (moderate). The 2025 annual accounts show equity of €14,824 and a net result of €10,673. The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
No sitting directors in the Gazette act read. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.